Cumberland Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 58.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
40.2%	A. Kazimi	5,695,557	US$8.9m	-0.45%	no data
3.83%	Renaissance Technologies LLC	542,663	US$846.6k	-1.31%	no data
2.64%	The Vanguard Group, Inc.	374,251	US$583.8k	0%	no data
2.52%	Dimensional Fund Advisors LP	357,615	US$557.9k	-2.27%	no data
2.02%	Bridgeway Capital Management, LLC	286,655	US$447.2k	0%	0.01%
1.7%	Kenneth Krogulski	241,277	US$376.4k	2.12%	no data
1.33%	Acadian Asset Management LLC	188,164	US$293.5k	0%	no data
0.78%	BlackRock, Inc.	110,564	US$172.5k	-0.38%	no data
0.6%	Geode Capital Management, LLC	84,522	US$131.9k	-0.88%	no data
0.53%	BNY Asset Management	75,268	US$117.4k	0%	no data
0.42%	Joseph Galante	59,356	US$92.6k	1.71%	no data
0.27%	James Herman	38,255	US$59.7k	-3.01%	no data
0.24%	State Street Global Advisors, Inc.	33,700	US$52.6k	-15.3%	no data
0.24%	James Jones	33,407	US$52.1k	3.09%	no data
0.23%	Two Sigma Investments, LP	32,430	US$50.6k	-1.82%	no data
0.19%	Caroline Young	26,701	US$41.7k	3.89%	no data
0.18%	John Hamm	26,003	US$40.6k	-1.68%	no data
0.16%	Two Sigma Advisers, LP	23,000	US$35.9k	-1.71%	no data
0.12%	Northern Trust Global Investments	16,338	US$25.5k	-10.2%	no data
0.12%	Todd Anthony	16,328	US$25.5k	-4.76%	no data
0.085%	Cresset Asset Management, LLC	12,025	US$18.8k	0%	no data
0.08%	Morgan Stanley, Investment Banking and Brokerage Investments	11,274	US$17.6k	0%	no data
0.042%	Martin Brown	6,000	US$9.4k	20%	no data
0.041%	Tower Research Capital LLC	5,747	US$9.0k	2.11%	no data
0.033%	Chris Bitterman	4,683	US$7.3k	-11.2%	no data